These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22207083)
1. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells. Vollmer G; Helle J; Amri H; Liu X; Arnold JT J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083 [TBL] [Abstract][Full Text] [Related]
2. Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells. Arnold JT; Gray NE; Jacobowitz K; Viswanathan L; Cheung PW; McFann KK; Le H; Blackman MR J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):240-6. PubMed ID: 18621129 [TBL] [Abstract][Full Text] [Related]
3. Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines. Gray NE; Liu X; Choi R; Blackman MR; Arnold JT Cancer Prev Res (Phila); 2009 Feb; 2(2):134-42. PubMed ID: 19141600 [TBL] [Abstract][Full Text] [Related]
4. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment? Piao YS; Wiesenfeld P; Sprando R; Arnold JT J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469 [TBL] [Abstract][Full Text] [Related]
6. CYP7B generates a selective estrogen receptor beta agonist in human prostate. Martin C; Ross M; Chapman KE; Andrew R; Bollina P; Seckl JR; Habib FK J Clin Endocrinol Metab; 2004 Jun; 89(6):2928-35. PubMed ID: 15181079 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells. Liu X; Piao YS; Arnold JT Carcinogenesis; 2011 Nov; 32(11):1648-54. PubMed ID: 21914638 [TBL] [Abstract][Full Text] [Related]
8. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells. Liu X; Choi RY; Jawad SM; Arnold JT Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436 [TBL] [Abstract][Full Text] [Related]
9. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H; Arnold JT; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
11. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665 [TBL] [Abstract][Full Text] [Related]
12. SEMA3C induces androgen synthesis in prostatic stromal cells through paracrine signaling. Yenki P; Adomat HH; Ong CJ Prostate; 2021 May; 81(6):309-317. PubMed ID: 33503318 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators. Yu S; Wang MW; Yao X; Chan FL Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023 [TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. Sun HZ; Yang TW; Zang WJ; Wu SF J Endocrinol; 2010 Mar; 204(3):311-8. PubMed ID: 20007738 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor agonist EB1089 is a potent regulator of prostatic "intracrine" metabolism. Doherty D; Dvorkin SA; Rodriguez EP; Thompson PD Prostate; 2014 Feb; 74(3):273-85. PubMed ID: 24242708 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
17. Steroid derivatives as pure antagonists of the androgen receptor. Gauthier S; Martel C; Labrie F J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):93-104. PubMed ID: 22449547 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities. Attardi BJ; Page ST; Hild SA; Coss CC; Matsumoto AM J Steroid Biochem Mol Biol; 2010 Feb; 118(3):151-61. PubMed ID: 19941958 [TBL] [Abstract][Full Text] [Related]
19. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients. Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851 [TBL] [Abstract][Full Text] [Related]
20. Stromal-epithelial interactions are responsible for prostate tumor progression through an androgen-related mechanism. Sharma H; Sissung TM; Pressler H; Figg WD Cancer Biol Ther; 2010 Feb; 9(3):163-5. PubMed ID: 20087060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]